casa pharma tirzepatide - 120mg More effective than semaglutide Compounded Tirzepatide (GLP-1/GIP)

Early changes are often related to water weight, digestion, or inflammation rather than fat loss

G.DlanoFrierJ

Author International Federation of Health Plans

Excess fat deposited in visceral adipose tissue and ectopic depots (such as muscle and liver) has also been related to increased cardiometabolic risk, as has a greater fat-to-lean mass proportion (e.g., normal-weight metabolically obese) [3]

Main Benefits: Supports fat burning

This could explain why tirzepatide (which stimulates the GIP pathway in addition to GLP -1) can be administered at higher doses than semaglutide (which only stimulates GLP-1), without amplifying the side effects typical of GLP-1 agonists (nausea, vomiting)